AbCellera Biologics Inc. (ABCL) Deep Dive Video

Summary

AbCellera is a cash-rich, AI-enabled antibody platform company transforming into a clinical biotech, with ABCL635 creating a high-upside but binary catalyst in a $6B menopause treatment market.

View ABCL stock page · Read the ABCL research report

Loading the video player…